• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


Price not available for VRBCF:US

Snapshot for Virbac SA (VRBCF)

Open: - Day's Range: - Volume: 0
Previous Close: 241.2500 52wk Range: 198.4500 - 241.2500 1-Yr Rtn: -

Stock Chart for VRBCF

No chart data available.
  • VRBCF:US 241.2500
  • 1M
  • 1Y
Interactive VRBCF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VRBCF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 23.5954
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 7.6120
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 8.46
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.07%
Cash Dividend (EUR) 1.9000
Dividend Ex-Date 06/20/2014
5 Year Dividend Growth 8.61%
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VRBCF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for VRBCF

Virbac SA manufactures antibiotics, worm medicines, and vaccines for veterinary use. The Company's products are distributed in the United States, Europe, Asia and South America.

Eric MareeChairman-Mgmt BoardMichel GaraudetChief Financial Officer
Christian KarstExec VP:Corporate DevSebastien HuronDir:Commercial Ops
More Company Profile & Key Executives for VRBCF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil